Combination of Uric Acid and Pro-Inflammatory Cytokines in Discriminating Patients with Gout from Healthy Controls
Xuwen Zha,Bo Yang,Guangyun Xia,Shan Wang
DOI: https://doi.org/10.2147/JIR.S357159
IF: 4.5
2022-02-28
Journal of Inflammation Research
Abstract:Xuwen Zha, 1, &ast Bo Yang, 2, &ast Guangyun Xia, 1 Shan Wang 1 1 Department of Rheumatology and Immunology, The First People's Hospital of Hefei, Binhu Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230000, People's Republic of China; 2 Department of Burn & Plastic Surgery, The First People's Hospital of Hefei, Binhu Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guangyun Xia; Shan Wang, Department of Rheumatology and Immunology, The First People's Hospital of Hefei, Binhu Hospital of Hefei, The Third Affiliated Hospital of Anhui Medical University, Hefei, 230000, People's Republic of China, Email ; Objective: The aim of present study was to explore whether the combination of serum uric acid and pro-inflammatory cytokines could improve the accuracy of diagnosis of gout. Methods: A total of 94 patients with gout were selected as the patient group, and 52 healthy subjects were selected as the control group. Serum levels of uric acid and pro-inflammatory cytokines (C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)) were measured in both groups. Correlation between serum uric acid and pro-inflammatory cytokines was assessed using Pearson correlation analysis. The area under curve (AUC) of CRP, IL-6, TNF-α combined with uric acid for the diagnosis of gout were evaluated by receiver operating characteristic (ROC) curve method. Results: Compared with the control group, the levels of serum uric acid, CRP, TNF-α and IL-6 were significantly increased in the patients. Moreover, there was a positive correlation between serum uric acid and CRP ( r = 0.179, P = 0.033), IL-6 ( r = 0.194, P = 0.039), and TNF-α ( r = 0.496, P < 0.001) levels. Furthermore, the AUCs of CRP, IL-6, TNF-α combined with uric acid level for the diagnosis of gout were 0.932, 0.884, and 0.972, respectively. Additionally, the AUC for the combination of uric acid, CRP, and TNF-α was 0.982 in discriminating patients with gout from healthy volunteers. Conclusion: The combination of serum uric acid and pro-inflammatory cytokines could improve the accuracy of diagnosis of gout. Keywords: gout, uric acid, pro-inflammatory cytokine, diagnosis Gout, characterized by the deposition of monosodium urate crystals (MSU) in joints and tendons, is the most common form of inflammatory arthritis. 1 The prevalence of gout varies among ethnic groups with overall lower frequency in Europe (0.9–2.5%) and America (3.9%) as compared to some Oceanic-Pacific ethnic groups (over 6%). 2 Despite the availability of valid therapeutic options, gout is often misdiagnosed and its long-term management is suboptimal. 3,4 Detection of MSU crystals in synovial fluid is the gold standard for diagnosis of gout, however, this is rarely performed for the reason that obtaining a sample may be technically difficult, painful for the patient and the accuracy of the results may be affected by multiple factors. 5 Other diagnostic methods such as X-ray, dual-source CT (DSCT), magnetic resonance imaging (MRI), and high-frequency ultrasound also have disadvantages such as inability to assess early soft tissue changes, low positive rates, and high prices. 6,7 Hyperuricemia, defined as a serum urate level above the upper limit of the normal reference range, is considered an important biochemical detection marker for the diagnosis of gout. 8–10 Epidemiological data show that serum uric acid levels are closely related to the incident gout. 11 However, emerging evidence suggest that not all hyperuricaemic patients have or will develop gout. 12,13 Thus, 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout suggests that the diagnosis of gout should not be made on the presence of hyperuricaemia alone. 13 Therefore, it is of great clinical significance to explore efficient biochemical markers to improve the accuracy of uric acid in the diagnosis of gout. Gout is now regarded as systemic inflammatory disease driven by activation of the innate immune system. 14 Studies on the underlying mechanisms of gouty inflammation provide remarkable insights into the inflammasome and pro-inflammatory cytokine release. Specifically, tumor necrosis factor-α (TNF-α), some interleukins, and NOD-like receptor protein 3 (NLRP3) inflammasome mediate the development of gout and induce a series of cascade inflammatory amplificati -Abstract Truncated-
immunology